 Avadel Pharmaceuticals LUMRYZ FT218, with its essential once daily dosing, has snagged a tentative approval from the FDA. Once finally approved, LUMRYZ has serious prospects for knocking off Jazzs flawed blockbuster XYREMXYWAV duopoly. 